奧園健康(03662.HK)擬以2.5億人幣購內地物管公司
奧園健康(03662.HK)公布,擬以2.48億元人民幣收購樂生活智慧社區服務集團。於框架協議日期,賣方合共持有目標公司股份70.82%。根據框架協議,賣方承諾負責完成向目標公司若干少數股東收購9.18%,以確保完成框架協議項下擬進行之交易。交易完成後,買方將合共持有目標公司全部股本之80%。
目標公司主要於中國從事提供物業管理服務。管理208個項目,物業總建築面積約2,263萬平方米,該等項目主要位於中國北京市、河北省、河南省、天津市、重慶市及四川省。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.